Cytokinetics 10-k
WebApr 8, 2024 · Cytokinetics Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2024 10-K Annual Report includes: Voting Procedures; Board Members; ... Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats. Last10K.com Member Feature. Export Annual and Quarterly Reports to Adobe Acrobat (PDF), Microsoft Word … Web2 days ago · Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility.
Cytokinetics 10-k
Did you know?
WebJul 30, 2014 · Company Provides Updates to Development Programs Focused to Muscle Biology SOUTH SAN FRANCISCO, CA, July 30, 2014 - Cytokinetics, Incorporated (Nasdaq: CYTK) reported total research and development ... WebThis Amendment No. 6 to the Agreement (this “Amendment No. 6”) is entered into as of June 11, 2013 (the “Amendment Effective Date”) by and between Cytokinetics, Incorporated (“Cytokinetics”), a Delaware corporation, having its principal place of business at 280 East Grand Ave., South San Francisco, California 94080 and Amgen Inc., a ...
WebGet the latest Cytokinetics, Inc. (CYTK) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment … WebCytokinetics is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics that modulate muscle function for the …
WebCYTK Cytokinetics Inc Annual Report (10-k) Securities registered pursuant to Section 12(g) of the Act: None . Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. WebCYTK Cytokinetics Inc Annual Report (10-k) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☑ ANNUAL …
WebMar 1, 2024 · SOUTH SAN FRANCISCO, Calif., March 01, 2024(GLOBE NEWSWIRE) -- Cytokinetics, Incorporated(Nasdaq: CYTK) reported financial results for the fourth …
WebApr 10, 2024 · SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, … green switch platesWebOct 25, 2024 · Cytokinetics expects that it will end 2024 with more than $800 million in cash. This, despite the fact that it expects that its operating expenses for all of 2024 to end up being in the range of... fnaf sister location minireenaWebMar 31, 2024 · Cytokinetics is committed to our mission of developing potential medicines that may improve the healthspan of people living with cardiovascular and neuromuscular diseases of impaired muscle function. … green switch pro controllerWebCytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential … green switch signify singaporeWebApr 10, 2024 · SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 22 nd Annual Needham Virtual Healthcare Conference on Monday, April 17, 2024 at 10:00 … green switch palaceWebDec 31, 2024 · On November 23, 2024, we announced that Amgen has elected to terminate the Amgen Agreement and thereby end its collaboration with Cytokinetics, effective May 20, 2024, and intends to transition … fnaf sister location night 5 tipsWebOct 10, 2024 · Cytokinetics aims to enroll 555 patients with ALS in its study, called COURAGE-ALS, and testing the company’s drug reldesemtiv against a placebo. The two groups will be compared on a rating scale of ALS symptoms known as ALSFRS-R after 24 weeks. The company began COURAGE-ALS in August 2024, a little more than two … fnaf sister location oc